Big Pharma Split Stock Performance

Big Pharma Relative Risk vs. Return Landscape

If you would invest  1,226  in Big Pharma Split on November 10, 2025 and sell it today you would earn a total of  247.00  from holding Big Pharma Split or generate 20.15% return on investment over 90 days. Big Pharma Split is generating 0.3082% of daily returns assuming 1.8352% volatility of returns over the 90 days investment horizon. Simply put, 16% of all stocks have less volatile historical return distribution than Big Pharma, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.Assuming the 90 days trading horizon Big Pharma is expected to generate 2.26 times more return on investment than the market. However, the company is 2.26 times more volatile than its market benchmark. It trades about 0.17 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Big Pharma Target Price Odds to finish over Current Price

Assuming the 90 days trading horizon Big Pharma has a beta of 0.25 indicating as returns on the market go up, Big Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Big Pharma Split will be expected to be much smaller as well. Additionally Big Pharma Split has an alpha of 0.3023, implying that it can generate a 0.3 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Big Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Big Pharma Split. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 12.92 14.76 16.60 Details

Intrinsic Valuation Low Real High 13.26 16.74 18.58 Details

Big Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Big Pharma is not an exception. The market had few large corrections towards the Big Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Big Pharma Split, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Big Pharma within the framework of very fundamental risk indicators.

Big Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Big Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Big Pharma Split can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Big Pharma Price Density Drivers

Big Pharma Fundamentals Growth

Big Pharma financial ratios help investors to determine whether Big Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Big with respect to the benefits of owning Big Pharma security.